Results 171 to 180 of about 4,304,560 (276)

IgA and IgM-enriched Immunoglobulins in Primary Immunodeficiencies: a Pilot Study. [PDF]

J Clin Immunol
Collet A, Coiffard B, Ledoult E, Fieschi C, Cheminant M, Serris A, Suarez F, Sanges S, Neel A, Nove-Josserand R, Stabler S, El Husseini K, Huault A, Cougoul P, Mausservey C, Cassir N, Mirgot F, Meresse B, Dendooven A, Poizot S, Le Scornet T, Bravard AS, Conrad A, Levêque M, Fadlallah J, Melenotte C, De La Roque CD, Tinevez C, Chahla WA, Dubucquoi S, Labalette M, Neven B, Malphettes M, Schleinitz N, Galicier L, Viallard JF, Gorochov G, Lefèvre G.   +37 more
europepmc   +1 more source

Targeted treatment of autoimmune cytopenias in primary immunodeficiencies. [PDF]

Front Immunol, 2022
Pacillo L, Giardino G, Amodio D, Giancotta C, Rivalta B, Rotulo GA, Manno EC, Cifaldi C, Palumbo G, Pignata C, Palma P, Rossi P, Finocchi A, Cancrini C.   +13 more
europepmc   +1 more source

Pharmacokinetic modelling of intravenous immunoglobulin in children with primary immunodeficiencies and secondary antibody deficiencies. [PDF]

Br J Clin Pharmacol
Cheng IL, Huang ZH, Worth A, Booth C, Standing JF.   +4 more
europepmc   +1 more source

Editorial: Advances in primary immunodeficiencies (inborn errors of immunity) in Central-Eastern Europe, volume II. [PDF]

Front Immunol, 2023
Pac M, Casanova JL, Tuzankina I, Maródi L.   +3 more
europepmc   +1 more source

Pharmacogenomics of dolutegravir: A scoping review of evidence, gaps and clinical implications

British Journal of Clinical Pharmacology, EarlyView.
Dolutegravir underpins modern first‐ and second‐line HIV treatment regimens; however, interindividual variability in its disposition and tolerability presents challenges for optimal use. This scoping review mapped current evidence on the pharmacogenomics of dolutegravir, focusing on pharmacokinetics and pharmacodynamics, and methodological limitations ...
Ronald Kiguba, Mishael Ssesanga, Munir Pirmohamed   +2 more
wiley   +1 more source

Psychological Symptoms in Primary Immunodeficiencies: a Common Comorbidity? [PDF]

J Clin Immunol, 2022
Manusama OR, van Beveren NJM, van Hagen PM, Drexhage HA, Dalm VASH.   +4 more
europepmc   +1 more source

Pharmacokinetic Assessment of Atazanavir and Favipiravir Following Echinacea Supplementation: A Controlled Herb–Drug Interaction Investigation

Biopharmaceutics &Drug Disposition, EarlyView.
Pharmacokinetic interactions between Echinacea and two antiviral drugs, favipiravir and atazanavir, were assessed in rats. The findings suggest that Echinacea does not significantly affect the pharmacokinetics of favipiravir and atazanavir. These results provide preliminary evidence that concurrent use of Echinacea with these antiviral drugs may be ...
Siva Nageswara Rao Gajula, Jeevan Sai Kallam, Aarika Kanukolanu, Ganesh Korada, Lakshmi Vineela Nalla   +4 more
wiley   +1 more source

Graduate-level medical doctors in Uganda have limited awareness of warning, specific signs, and immunological investigations of primary immunodeficiencies. [PDF]

Front Immunol
Sande OJ, Matovu B, Kongai T, Olobo J.
europepmc   +1 more source

Severity of SARS-CoV-2 infection in children with inborn errors of immunity (primary immunodeficiencies): a systematic review. [PDF]

Allergy Asthma Clin Immunol, 2023
Alhumaid S, Al Mutared KM, Al Alawi Z, Sabr Z, Alkhars O, Alabdulqader M, Al Dossary N, ALShakhs FM, Majzoub RA, Alalawi YH, Al Noaim K, Alnaim AA, Al Ghamdi MA, Alahmari AA, Albattat SS, Almubarak YS, Al Abdulmohsen EM, Al Shaikh H, Alobaidan ME, Almusallam HH, Alhassan FM, Alamer MA, Al-Hajji JA, Al-Hajji DA, Alkadi AA, Al Mutair A, Rabaan AA.   +26 more
europepmc   +1 more source

Isolating T‐Cell Potent Lentiviral Vector Subpopulations through Rational Design of Nanofiber Anion‐Exchange Adsorbents

Biotechnology and Bioengineering, EarlyView.
ABSTRACT Generation of CAR‐T cell therapies relies predominantly on lentiviral vectors (LVs). As in vivo CAR‐T trials progress, demand for larger quantities of higher‐potency LV is expected. However, primary capture by anion‐exchange chromatography (AIEX) remains a major manufacturing bottleneck from use of adsorbents not tailored to LVs, leading to ...
George Pamenter, Gyorgy Ovari, Anurag Kulkarni, Thomas Williams‐Fegredo, Carol Knevelman, Kyriacos Mitrophanous, Lee Davies, Farzad Foroutan, Matthew Townsend, Stephen Goldrick, Daniel G. Bracewell   +10 more
wiley   +1 more source